C-MER Medical repurchases 290,000 shares; treasury stock lifted to 20.91 million

Bulletin Express07-02

Hong Kong – 2 July 2026 – C-MER Medical Holdings Limited announced a market repurchase of 290,000 ordinary shares on 2 July 2026, according to its Next Day Disclosure Return filed with the Stock Exchange of Hong Kong.

The shares were bought back on-market at prices between HK$0.95 and HK$0.96, translating into a volume-weighted average cost of HK$0.9534 per share and an aggregate consideration of HK$0.28 million.

Following the transaction: • Issued shares (excluding treasury stock) decreased by 0.02 % to 1.21 billion. • Treasury shares increased from 20.62 million to 20.91 million. • Total issued shares remained unchanged at 1.23 billion, as the repurchased shares are being held in treasury rather than cancelled.

The buy-back was executed under the repurchase mandate approved on 20 May 2026, which authorises up to 123.23 million shares. To date, 290,000 shares—equivalent to 0.02 % of the share capital on the mandate date—have been repurchased. A moratorium on new share issues or treasury share sales is in force until 1 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1164202290?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-02 17:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164202290","market":"us","top_or_hot":-1,"title":"C-MER Medical repurchases 290,000 shares; treasury stock lifted to 20.91 million","media":"Bulletin Express","content":"<p>Hong Kong – 2 July 2026 – C-MER Medical Holdings Limited announced a market repurchase of 290,000 ordinary shares on 2 July 2026, according to its Next Day Disclosure Return filed with the Stock Exchange of Hong Kong.</p>\n<p>The shares were bought back on-market at prices between HK$0.95 and HK$0.96, translating into a volume-weighted average cost of HK$0.9534 per share and an aggregate consideration of HK$0.28 million.</p>\n<p>Following the transaction:\n• Issued shares (excluding treasury stock) decreased by 0.02 % to 1.21 billion.  \n• Treasury shares increased from 20.62 million to 20.91 million.  \n• Total issued shares remained unchanged at 1.23 billion, as the repurchased shares are being held in treasury rather than cancelled.</p>\n<p>The buy-back was executed under the repurchase mandate approved on 20 May 2026, which authorises up to 123.23 million shares. To date, 290,000 shares—equivalent to 0.02 % of the share capital on the mandate date—have been repurchased. A moratorium on new share issues or treasury share sales is in force until 1 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER Medical repurchases 290,000 shares; treasury stock lifted to 20.91 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER Medical repurchases 290,000 shares; treasury stock lifted to 20.91 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-02 17:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong – 2 July 2026 – C-MER Medical Holdings Limited announced a market repurchase of 290,000 ordinary shares on 2 July 2026, according to its Next Day Disclosure Return filed with the Stock Exchange of Hong Kong.</p>\n<p>The shares were bought back on-market at prices between HK$0.95 and HK$0.96, translating into a volume-weighted average cost of HK$0.9534 per share and an aggregate consideration of HK$0.28 million.</p>\n<p>Following the transaction:\n• Issued shares (excluding treasury stock) decreased by 0.02 % to 1.21 billion.  \n• Treasury shares increased from 20.62 million to 20.91 million.  \n• Total issued shares remained unchanged at 1.23 billion, as the repurchased shares are being held in treasury rather than cancelled.</p>\n<p>The buy-back was executed under the repurchase mandate approved on 20 May 2026, which authorises up to 123.23 million shares. To date, 290,000 shares—equivalent to 0.02 % of the share capital on the mandate date—have been repurchased. A moratorium on new share issues or treasury share sales is in force until 1 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1164202290","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164202290","pubTimestamp":1782985579,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong – 2 July 2026 – C-MER Medical Holdings Limited announced a market repurchase of 290,000 ordinary shares on 2 July 2026, according to its Next Day Disclosure Return filed with the Stock...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER医疗回购29万股；库存股增至2091万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"Hong Kong – 2 July 2026 – C-MER Medical Holdings Limited announced a market repurchase of 290,000 ordinary shares on 2 July 2026, according to its Next Day Disclosure Return filed with the Stock Exchange of Hong Kong.\nThe shares were bought back on-market at prices between HK$0.95 and HK$0.96, translating into a volume-weighted average cost of HK$0.9534 per share and an aggregate consideration of HK$0.28 million.\nFollowing the transaction:\n• Issued shares (excluding treasury stock) decreased by 0.02 % to 1.21 billion.  \n• Treasury shares increased from 20.62 million to 20.91 million.  \n• Total issued shares remained unchanged at 1.23 billion, as the repurchased shares are being held in treasury rather than cancelled.\nThe buy-back was executed under the repurchase mandate approved on 20 May 2026, which authorises up to 123.23 million shares. To date, 290,000 shares—equivalent to 0.02 % of the share capital on the mandate date—have been repurchased. A moratorium on new share issues or treasury share sales is in force until 1 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1164202290","isCrawlerRequest":true}